Literature DB >> 19141124

Clinical Immunology Review Series: An approach to the patient with allergy in childhood.

R Sporik1, J Henderson, J O'B Hourihane.   

Abstract

Allergic conditions are common, with asthma being the most common chronic illness in childhood in most developed countries. Some 80% of asthmatic children are sensitized to aeroallergens, usually indoor animal dander and house dust mite. Some 80% of asthmatics also have rhinitis. Rhinitis and eczema receive less medical attention than asthma, but they can cause longterm morbidity and have substantial direct and indirect economic costs. Food allergy and anaphylaxis are increasingly recognised and are usually easily diagnosed and managed.Clinicians can use in vivo and in vitro measurements of allergen-specific immunoglobulin E to better time reintroduction of implicated foods. Specific parenteral and sublingual immunotherapy is widely practiced internationally but is uncommon in the UK. It may alter the natural history of aeroallergen reactive diseases in the upper and lower airways. Specific oral tolerance induction represents the current cutting edge in clinical allergy research. It remands resource intensive at present and cannot be adopted into routine clinical practice at this time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141124      PMCID: PMC2669513          DOI: 10.1111/j.1365-2249.2008.03852.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  75 in total

1.  Personal exposure to allergenic pollen and mould spores in inland New South Wales, Australia.

Authors:  T Z Mitakakis; E R Tovey; W Xuan; G B Marks
Journal:  Clin Exp Allergy       Date:  2000-12       Impact factor: 5.018

2.  Food allergy--getting more out of your skin prick tests.

Authors:  G Roberts; G Lack
Journal:  Clin Exp Allergy       Date:  2000-11       Impact factor: 5.018

3.  Incidence of severe and fatal reactions to foods.

Authors:  J O'B Hourihane; D Reading; P Smith; G Lack; D Hill; A Muñoz-Furlong; S A Bock
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

4.  Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice.

Authors:  P W Ewan; A T Clark
Journal:  Clin Exp Allergy       Date:  2005-06       Impact factor: 5.018

5.  Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

Authors:  Christian Möller; Sten Dreborg; Hosne A Ferdousi; Susanne Halken; Arne Høst; Lars Jacobsen; Antti Koivikko; Dieter Y Koller; Bodo Niggemann; Lene A Norberg; Radvan Urbanek; Erkka Valovirta; Ulrich Wahn
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

6.  Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life.

Authors:  S A Bock
Journal:  Pediatrics       Date:  1987-05       Impact factor: 7.124

Review 7.  Update on food allergy.

Authors:  Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2004-05       Impact factor: 10.793

Review 8.  Clinical immunology review series: an approach to the use of the immunology laboratory in the diagnosis of clinical allergy.

Authors:  P Williams; W A C Sewell; C Bunn; R Pumphrey; G Read; S Jolles
Journal:  Clin Exp Immunol       Date:  2008-07       Impact factor: 4.330

Review 9.  An approach to the patient with urticaria.

Authors:  S J Deacock
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

10.  Prevalence of sensitization reported and objectively assessed food hypersensitivity amongst six-year-old children: a population-based study.

Authors:  Carina Venter; Brett Pereira; Jane Grundy; C B Clayton; S H Arshad; Taraneh Dean
Journal:  Pediatr Allergy Immunol       Date:  2006-08       Impact factor: 6.377

View more
  1 in total

Review 1.  Diagnosis of allergy and asthma in childhood.

Authors:  Carlos E Baena-Cagnani; Héctor A Badellino
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.